Chronic Migraine Research
Explore research on chronic migraine, migraine chronification, treatment and outcomes.
-
Sex-Specific Circadian Dysregulation in the Choroid Plexus of a Nitroglycerin Rat Model of Chronic Migraine: An RNA-Seq Analysis.
Authors: Woldeamanuel YW, Xia C, Ding S, Fonteh A, Arakaki X Laboratory / animal study
Chronic migraines can cause changes in the choroid plexus (CP), affecting the blood-CSF barrier. This study looked at how CP circadian genes relate to migraines. Researchers used Sprague-Dawley rats, treating some…
-
Sustained response to atogepant in episodic and chronic migraine: Post-hoc analyses of ELEVATE and PROGRESS, and their open-label extension.
Authors: Cho SJ, Friedman DI, Chalermpalanupap N, Nahas SJ, Dabruzzo B Clinical trial
These analyses looked at how effective atogepant is for migraine treatment. Atogepant is a daily pill that blocks certain pain signals. Researchers studied data from two trials called ELEVATE and PROGRESS. They also…
-
The Impact of Psychological Therapies on Well-Being and Quality of Life in Adult Chronic Migraine Patients: A Systematic Review.
Authors: Ellis CH, Jones DW, Wakerley BR, Snuggs S Systematic review / meta-analysis
Chronic migraine affects many people, causing at least 15 headache days monthly. These headaches can severely impact daily life and often come with insomnia and emotional issues. Researchers are looking into…
-
mGluR5-PKCγ signaling disrupts the AMPA receptor subunit homeostasis and drives central sensitization in chronic migraine.
Authors: Liu X, Yang Y, Zhong J, Zhang W, Wu Q Laboratory / animal study
Chronic migraine (CM) is linked to changes in brain signaling and pain perception. Researchers studied how certain receptors affect nerve cell behavior in a rat model. They found that a receptor called mGluR5 becomes…
-
Non-response in chronic migraine: separating residual afferent drive from drive-independent persistence.
Authors: Sulter GA Review
Many patients with chronic migraines struggle to find effective treatments. About 33% do not respond to any preventive drugs available. This includes medications like CGRP antibodies and onabotulinumtoxinA…
-
Efficacy of pulsed radiofrequency combined with greater occipital nerve blockade in refractory chronic migraine.
Authors: Karaduman Y, Muz A, Gündoğan S, İren YH, Durmuş İE Observational study
Chronic migraine can significantly affect a person's quality of life. Many treatments do not work for everyone. Greater occipital nerve blockade is a common treatment for migraines. This study looked at adding pulsed…
-
Cost-effectiveness of onabotulinumtoxinA versus topiramate in chronic migraine in the US: an economic analysis of the FORWARD randomized trial.
Authors: Ronquest N, Zhang Y, Park TJ, Campbell K, Anderson S Clinical trial
This study compared the cost-effectiveness of two migraine treatments: OnabotA and topiramate. Researchers focused on chronic migraine patients in the US. They used a complex model to evaluate costs and benefits over…
-
Quantitative Oculomotor Abnormalities in Episodic and Chronic Migraine: A Cross-Sectional Comparative Study.
Authors: Li Y, Gao Z, Zhu C, Qiu L, Yang Z Observational study
Migraine is a common headache disorder that may affect eye movements. Researchers studied differences in eye movement between episodic migraine (EM) and chronic migraine (CM). They included 242 migraine patients and…
-
Microglia TREM1 promotes lipid droplet accumulation and microglia M1 polarization via NF-κB pathway to induce neuroinflammation-mediated central sensitization in chronic migraine.
Authors: Luo J, Feng L, Xu W, Lang J, Wang L Laboratory / animal study
Chronic migraine (CM) is linked to neuroinflammation and heightened sensitivity to pain. Researchers studied the role of TREM1, a receptor that influences inflammation in glial cells. They used mouse models of CM and…
-
COVID-19 Vaccination and the Risk of Migraine Chronification: A Comparative Cohort Study of Vaccinated and Unvaccinated Patients With Episodic Migraine.
Authors: Meshref M, Younis H, Ahmed KAHM, Abed E, Abbas A Observational study
This study looked at whether COVID-19 vaccination affects migraine patients. Researchers followed 60 adults with episodic migraines for six months. Half of these patients were vaccinated, and half were not. They…
-
GLP-1 receptor activation attenuates chronic migraine-like behaviour: Sex-specific modulation of opioid- and endocannabinoid-related pathways.
Authors: Sićović K, Nastić K, Dinić M, Brdarić E, Pecikoza U Laboratory / animal study
Chronic migraine is a debilitating condition that often goes untreated. Researchers investigated how GLP-1 receptor agonists, like liraglutide and semaglutide, affect chronic migraine symptoms. These drugs are…
-
Procedural interventions for chronic migraine: an umbrella review intervention-specific evidence map.
Authors: Xia L, Yang D, Lu Y, Gong Y, Zhang C Systematic review / meta-analysis
This research paper reviews different procedures used to treat chronic migraines. Chronic migraine affects many people and can severely impact their quality of life. The study looked at various treatments, including…
-
Impact of sphenopalatine ganglion blocks on high-frequency episodic and chronic migraine: A retrospective study.
Authors: Vinciguerra L, Brusaferri F, Zito A, Saponara R, Paletta R Clinical trial
This study looked at the effectiveness and safety of sphenopalatine ganglion blocks for migraines. This procedure uses a special catheter to deliver local anesthetics directly to a specific nerve area. The…
-
Targeting neuronal FKBP5 attenuates mechanical allodynia by suppressing NF-κB-mediated neuroinflammation in an NTG-induced chronic migraine mouse model.
Authors: Peng C, Fan T, Zhou G, Zhao M, Wang T Laboratory / animal study
Chronic migraine is a painful condition that affects many people. This study focused on a protein called FKBP5 and its role in migraine. Researchers used a mouse model to investigate how FKBP5 affects pain and…
-
Opioid use, disability, and patient-reported cognitive impairment in migraine: Multi-country results from the Chronic Migraine Epidemiology and Outcomes-International Study.
Authors: Leroux E, Buse DC, Lanteri-Minet M, Sakai F, Matharu M Clinical trial
Opioids are often used by some patients to treat migraine, but they are not recommended. This study looked at people using opioids for migraines in six countries. Researchers wanted to understand the differences…
-
Comparative effectiveness and safety of topiramate versus amitriptyline for the prophylactic management of chronic migraine: a prospective comparative study.
Authors: Karami MM, Hassan A, Alkhotani A, Basheikh M, Badahdah A Clinical trial
Chronic migraine significantly affects people's lives and well-being. Topiramate and amitriptyline are two common medications for preventing migraines. This study compared their effectiveness and safety in treating…
-
Greater occipital nerve block versus intranasal sphenopalatine ganglion block in chronic migraine with failure of at least two oral preventive treatments: a prospective, non-randomised patient-preference comparative study.
Authors: Pektaş S, Turan SA Observational study
This study compared two treatments for chronic migraine: greater occipital nerve (GON) block and intranasal sphenopalatine ganglion (SPG) block. Both treatments were given to patients who failed at least two oral…
-
Cost-utility analysis of erenumab preventive treatment for chronic migraine in China.
Authors: Wang L, Zhu M, Hu Q, Lou S, Wu M Other / unclear
This study looked at the cost-effectiveness of erenumab for chronic migraine in China. Erenumab is a preventive treatment given as an injection every four weeks. Researchers compared its effects to no preventive…
-
COMPARATIVE EFFICACY OF 200 UNITS VERSUS 155 UNITS OF ONABOTULINUMTOXIN A FOR CHRONIC MIGRAINE.
Authors: Alkhaffaf W, Alkataan M Clinical trial
This study looked at how effective different doses of onabotulinumtoxin A (OnaBT-A) are for treating chronic migraine. Chronic migraine affects many people and can be hard to manage. Researchers conducted this study…
-
Investigating the mechanism of Xiongfu formula and its active ingredient Z-Ligustilide alleviates chronic migraine by modulating the MAPK/ERK/CREB pathway and microglia-mediated neuroinflammation.
Authors: Zhang Y, Jin L, Liu X, Shi W, Wang Q Laboratory / animal study
Chronic migraine is a painful condition that can disrupt daily life. Traditional Chinese medicine views it as a result of stagnated Qi and poor blood flow. The Xiongfu formula is a classic herbal remedy for…
